Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · IEX Real-Time Price · USD
1.780
-0.070 (-3.78%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $111.34 million as of July 2, 2024. Its market cap has increased by 9.16% in one year.
Market Cap
111.34M
Enterprise Value
90.25M
1-Year Change
9.16%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has decreased from $290.80M to $111.34M, a decrease of -61.71%. That is a compound annual growth rate of -10.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 115.70M | 34.07% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
| Mar 23, 2016 | 290.80M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regulus Therapeutics | 124.39M |
| Omega Therapeutics | 124.10M |
| Electromed | 122.48M |
| Tevogen Bio Holdings | 122.33M |
| Harvard Bioscience | 120.73M |
| Nuvectis Pharma | 113.44M |
| Assertio Holdings | 113.20M |
| DiaMedica Therapeutics | 111.99M |